Y Kakeji Selected Research

Squamous Cell Neoplasms (Squamous Cell Cancer)

12/2017

C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Kakeji Research Topics

Disease

14	Neoplasms (Cancer) 03/2021 - 04/2000
9	Stomach Neoplasms (Stomach Cancer) 12/2018 - 02/2000
7	Neoplasm Metastasis (Metastasis) 05/2014 - 09/2000
6	Esophageal Neoplasms (Esophageal Cancer) 03/2021 - 01/2007
6	Carcinoma (Carcinomatosis) 01/2005 - 09/2000
4	Lymphatic Metastasis 01/2001 - 03/2000
2	Esophageal Squamous Cell Carcinoma 03/2021 - 01/2004
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2005 - 01/2004
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2017
1	Inflammation (Inflammations) 12/2017
1	Fistula 09/2017
1	Anorexia 01/2016
1	Diarrhea 01/2016
1	Fatigue 01/2016
1	Colonic Neoplasms (Colon Cancer) 11/2015
1	Disease Progression 09/2015
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2014
1	Carcinogenesis 04/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2010
1	Pleural Effusion (Pleural Effusions) 01/2008
1	Acute Lung Injury 01/2008
1	Gastritis 09/2006
1	Chromosomal Instability (Chromosome Stability) 01/2001
1	Aneuploidy (Aneuploid) 01/2001
1	Hyperplasia 01/2001
1	Neoplasm Micrometastasis 09/2000
1	Breast Neoplasms (Breast Cancer) 04/2000

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2002 - 09/2000
4	Biological ProductsIBA 10/2001 - 02/2000
3	Indicators and Reagents (Reagents)IBA 05/2014 - 03/2002
3	Proteins (Proteins, Gene)FDA Link 10/2001 - 02/2000
2	UracilIBA 01/2016 - 11/2015
2	TegafurIBA 01/2016 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 01/2001
2	Messenger RNA (mRNA)IBA 09/2000 - 04/2000
1	AlbuminsIBA 12/2017
1	C-Reactive ProteinIBA 12/2017
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Leucovorin (Folinic Acid)FDA Link 11/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2015
1	S-1 plus cisplatinIBA 09/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2014
1	Bevacizumab (Avastin)FDA Link 05/2014
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2014
1	EnzymesIBA 04/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	CytokinesIBA 01/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2006
1	Blood Group Antigens (Blood Groups)IBA 01/2004
1	ABO Blood-Group SystemIBA 01/2004
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 03/2002
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2001
1	Vascular Endothelial Growth Factor CIBA 01/2001
1	Matrix Metalloproteinases (MMPs)IBA 09/2000
1	Keratins (Keratin)IBA 09/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2000
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2000

Therapy/Procedure

7	Esophagectomy 03/2021 - 01/2007
4	Lymph Node Excision (Lymph Node Dissection) 01/2005 - 03/2000
3	Drug Therapy (Chemotherapy) 09/2015 - 01/2007
2	Gastrectomy 12/2018 - 01/2013
2	Therapeutics 01/2016 - 09/2015
2	Adjuvant Chemotherapy 01/2016 - 11/2015
2	Chemoradiotherapy 01/2010 - 01/2007
1	Operative Surgical Procedures 03/2021
1	Length of Stay 01/2021
1	Duration of Therapy 11/2015
1	Operative Time 01/2008
1	Intravenous Injections 09/2006
1	Postoperative Care 01/2001
1	Perioperative Care 10/2000